Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
Strategies Trauma Limb Reconstr ; 9(1): 13-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24362757

ABSTRACT

Indications and techniques of locked plate fixation for the treatment of challenging fractures continue to evolve. As design variant of classic locked plates, the polyaxial locked plate has the ability to alter the screw angle and thereby, enhance fracture fixation. The aim of this observational study was to evaluate clinical and radiographic results in 89 patients with 90 fractures of the distal femur treated, between June 2006 and November 2011, with such a polyaxial locked plating system (Polyax™ Locked Plating System, DePuy, Warsaw, IN, USA). Seventy-seven fractures formed the report of this study. These cases were followed up until complete fracture healing or for a mean time of 77 weeks. At the time of last follow-up, 58 of 77 fractures (75.3 %) progressed to union without complication and radiographic healing occurred at a mean time of 16.3 weeks. Complications occurred in ten fractures that did not affect the healing and in nine fractures that showed delayed or non-union. The mean American Knee Society Score at the time of final follow-up was 83 for the Knee Score and 71.1 for the Functional Score. In conclusion, there is a high union rate for complex distal femoral fractures associated with a good clinical outcome in this series.

2.
Cell Prolif ; 44(4): 360-71, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21645151

ABSTRACT

OBJECTIVE: Alterations in plasma lipid profile and in intracellular cholesterol homoeostasis have been described in various malignancies; however, significance of these alterations, if any, in cancer biology is not clear. The aim of the present study was to investigate a possible correlation between alterations in cholesterol metabolism and expansion of leukaemia cell numbers. MATERIALS AND METHODS: Lipid profiles in plasma and in primary leukaemia cells isolated from patients with acute or chronic lymphocytic leukaemia (ALL and CLL) were studied. RESULTS AND CONCLUSIONS: Decreased levels of HDL-C were observed in plasma of leukaemic patients, levels of total cholesterol, LDL-C, triglycerides and phospholipids were unchanged or only slightly increased. As compared to normal lymphocytes, freshly isolated leukaemic cells showed increased levels of cholesterol esters and reduction in free cholesterol. Growth stimulation of ALL and CLL cells with phytohemagglutinin led to further increase in levels of cholesterol esters. Conversely, treatment with an inhibitor of cell proliferation such as the mTOR inhibitor, RAD, caused decline in population growth rate of leukaemia cells, which was preceded by sharp reduction in rate of cholesterol esterification. On the other hand, exposure of leukaemic cells to two inhibitors of cholesterol esterification, progesterone and SaH 58-035, caused 60% reduction in their proliferation rate. In addition to demonstrating tight correlation between cell number expansion and cholesterol esterification in leukaemic cells, these results suggest that pathways that control cholesterol esterification might represent a promising targets for novel anticancer strategies.


Subject(s)
Cholesterol Esters/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Adult , Aged , Amides/pharmacology , Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Cholesterol Esters/blood , Cholesterol, HDL/blood , Everolimus , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Lipid Metabolism/drug effects , Lipids/blood , Middle Aged , Organosilicon Compounds/pharmacology , Phytohemagglutinins/pharmacology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Progesterone/pharmacology , Sirolimus/analogs & derivatives , Sirolimus/pharmacology
3.
J Agric Food Chem ; 56(3): 1084-90, 2008 Feb 13.
Article in English | MEDLINE | ID: mdl-18181568

ABSTRACT

Pome trees, apple, pear, and quince, are classified into the subfamily Pomoideae, belonging to the Rosaceae family. Their autumnal fruits are consumed worldwide in different forms, that is, fresh or transformed into jams, jelly, juices, etc. Their well-established beneficial properties to human health were found mainly related to their phenolic content. Pulp and peel aqueous acetone extracts obtained from Tunisian fruits at commercial maturity were comparatively evaluated for their phenolic profiles and antioxidant and antimicrobial potentials. The phenolic compounds present in the extracts were identified and quantified using RP-HPLC-DAD and ESI-MS techniques. Significant differences in the chromatographic profiles among these fruits, as well as between pulp and peel extracts of each fruit, were observed. Quince, followed by 'Red Delicious', peel extracts showed the highest phenolic content (160.33 and 110.90 mg/100 g of fresh weight). The stronger inhibitory effect on DPPH radicals corresponded to those obtained from peel materials. A comparative analysis of the antimicrobial potential against a range of microorganism strains was also carried out. Staphylococcus aureus, Pseudomonas aeruginosa, and Bacillus cereus were the most sensitive to the active extracts. Among the examined phenolic extracts, 'Red Delicious' and quince peels showed the highest effects for inhibiting bacteria growth. Minimum inhibitory and bactericide concentrations ranged from 10(2) to 10(4) microg of polyphenol/mL. Red skin apple and quince peels could be of great interest as important antioxidant and antimicrobial polyphenol sources.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Flavonoids/analysis , Fruit/chemistry , Phenols/analysis , Plant Extracts/chemistry , Acetone , Chromatography, High Pressure Liquid , Malus/chemistry , Polyphenols , Pyrus/chemistry , Rosaceae/chemistry , Spectrometry, Mass, Electrospray Ionization , Tunisia
4.
Mech Ageing Dev ; 126(6-7): 648-54, 2005.
Article in English | MEDLINE | ID: mdl-15888318

ABSTRACT

The effects of ageing on the metabolism of cholesterol were examined in three different organs (liver, aorta and brain) of 6-, 12- and 24-month-old male Sprague-Dawley rats. Ageing was associated with a significant increase in intracellular cholesterol esters in all three organs. Steady state mRNA levels of multidrug resistance protein (MDR) and acylCoA:cholesterol acyl transferase (ACAT), enzymes involved in cholesterol import and esterification, were also increased. By contrast, expression of mRNA for neutral cholesterol ester hydrolase (nCEH) and caveolin-1, proteins involved in cholesterol ester hydrolysis and export, were significantly reduced. Dietary restriction is the only intervention shown to extend lifespan and retard age-related declines in function in mammals. To further explore the possible correlation between changes in cholesterol esterification and ageing, we analysed cholesterol metabolism in liver, aorta, and brain of aged rats exposed to two dietary restriction regimens: intermittent (alternate-day) fasting (IF) and food intake restriction (60% of ad libitum feeding). Both dietary regimens attenuated the age-related changes in cholesterol esters and in the expression of genes involved in cholesterol metabolism. These results provide evidence that distinctive age-associated changes in intracellular cholesterol metabolism occur in rats. Furthermore, these modifications can be partially reversed by dietary restriction, a condition known to affect the ageing process. Age-related changes in cholesterol metabolism may play a role in triggering and/or aggravating senescence-related disorders characterized by altered cholesterol homeostasis.


Subject(s)
Aging/metabolism , Cholesterol Esters/metabolism , Enzymes/biosynthesis , Fasting/metabolism , Gene Expression Regulation, Enzymologic/physiology , Animals , Aorta/metabolism , Brain/metabolism , Enzymes/genetics , Liver/metabolism , Male , Rats , Rats, Sprague-Dawley
5.
Cell Prolif ; 35(3): 143-54, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12027950

ABSTRACT

Atherosclerosis is an inflammatory-fibroproliferative response of the arterial wall involving a complex set of interconnected events where cell proliferation (lymphomonocytes, and endothelial and smooth-muscle cells) and substantial perturbations of intracellular cholesterol metabolism are considered to be among the main features. Glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the hexose-monophosphate shunt pathway, is an essential enzyme involved in both cell growth and cholesterol metabolism, raising the question as to whether G6PD deficiency may have metabolic and growth implications in a deficient population. In the present study, we investigated cell growth and cholesterol metabolism in peripheral blood lymphomononuclear cells (PBMC) from G6PD-normal (n = 5) and -deficient (n = 5) subjects stimulated with lectins (phytohaemoagglutinin and Concanavalin A). G6PD activity, DNA ([3H]-thymidine incorporation) cholesterol synthesis and esterification ([14C]-acetate and [14C]-oleate incorporation), and G6PD, HMGCoA reductase and low density lipoprotein (LDL) receptor mRNA levels (RT-PCR) all increased following lectin stimulation in both normal and G6PD-deficient cells. However, these parameters were significantly lower in G6PD-deficient cells (P < 0.05). It is of interest that G6PD-deficient PBMC, which showed lower expression of G6PD and higher expression of the LDL receptor gene than normal PBMC under basal conditions, exhibited an opposite pattern after stimulation: G6PD and HMGCoA reductase being expressed at significantly higher levels in deficient than in normal cells (P < 0.05). We conclude that the reduced capability of G6PD-deficient cells to respond to mitogenic stimuli and to synthesize cholesterol esters may represent favourable conditions for reducing the risk of cardiovascular diseases.


Subject(s)
Cholesterol/metabolism , Glucosephosphate Dehydrogenase Deficiency/enzymology , Glucosephosphate Dehydrogenase Deficiency/metabolism , Leukocytes, Mononuclear/enzymology , Leukocytes, Mononuclear/metabolism , Adult , Arteriosclerosis/etiology , Cell Division , Cells, Cultured , DNA/biosynthesis , Glucosephosphate Dehydrogenase/genetics , Glucosephosphate Dehydrogenase/metabolism , Glucosephosphate Dehydrogenase Deficiency/genetics , Humans , Hydroxymethylglutaryl CoA Reductases/biosynthesis , Hydroxymethylglutaryl CoA Reductases/genetics , Kinetics , Lipids/blood , Male , RNA, Messenger/biosynthesis , Receptors, LDL/biosynthesis , Receptors, LDL/genetics
6.
Int J Cosmet Sci ; 24(1): 53-9, 2002 Feb.
Article in English | MEDLINE | ID: mdl-18498495

ABSTRACT

The aim of this study was to evaluate the antimicrobial activity of selected essential oils (Laurus nobilis, Eucalyptus globulus and Salvia officinalis), both alone and in combination, in cosmetic preparations characterized by an increasing risk of microbial contamination, i.e. an O/W skin cream, a hydrogel and a non-alcoholic hydrolyte. Their potential synergistic effect in combination with the usual cosmetic preservatives at low concentrations (up to 200-fold less than usual) was also investigated.

7.
Cell Mol Life Sci ; 58(8): 1113-20, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11529503

ABSTRACT

Cholesterol esterification and smooth muscle cell (SMC) proliferation are the crucial events in the development of atherosclerotic lesions. The objective of this study was to analyse cholesterol esterification and the expression of MDR1 (multidrug resistance), ACAT (acyl-CoA:cholesterol acyltransferase) and caveolin-1 genes in atherosclerotic and healthy vascular walls, in SMCs obtained from atherosclerotic lesions and saphenous veins. Results demonstrated higher levels of cholesterol esters, ACAT and MDR1 mRNAs and lower levels of caveolin-1 mRNA in atherosclerotic segments compared to adjacent serial sections of the same artery and the corresponding non-atherosclerotic arteries from cadaveric donors. SMCs isolated from atherosclerotic plaques manifested an increased capacity to esterify cholesterol and to grow at a faster rate than SMCs isolated from saphenous veins. In addition, when SMCs from atherosclerotic plaques were cultured in the presence of progesterone, a potent inhibitor of cholesterol esterification, significant growth suppression was observed. An increase in ACAT and MDR1 expression and a concomitant decrease in caveolin-1 expression were also observed in SMCs isolated from atherosclerotic arteries as early as 12 h after serum stimulation. An opposite pattern was found when SMCs were treated with progesterone. These findings support the idea that cholesterol esterification plays a role both in early atherogenesis and in clinical progression of advanced lesions and raise the possibility that the cholesterol ester pathway might directly modulate the proliferation of SMCs.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Arteriosclerosis/metabolism , Caveolins/genetics , Gene Expression , Muscle, Smooth, Vascular/cytology , Adult , Aged , Arteriosclerosis/pathology , Caveolin 1 , Cell Division , Cells, Cultured , Cholesterol Esters/metabolism , Female , Humans , Lipid Metabolism , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Sterol O-Acyltransferase/genetics , Time Factors
8.
Eur J Vasc Endovasc Surg ; 22(1): 31-6, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11461099

ABSTRACT

OBJECTIVES: a positive correlation between cholesterol esterification, acyl-CoA:cholesterol acyltransferase (ACAT), multidrug resistance (MDR1) gene expression and atherosclerotic lesions has been shown in human arteries. The objective of this study was to map the expression of MDR1, ACAT genes and the cholesteryl ester content in normal, atherosclerotic and varicose human vessels. MATERIALS: vascular segments were obtained from seven cadaveric donors, 27 patients undergoing vascular surgery for severe atherosclerotic disease and 11 patients with saphenous vein varicosities. METHODS: lipid analysis and RT-PCR of MDR1 and ACAT mRNAs were performed. RESULTS: an increase in cholesteryl ester content and in ACAT and MDR1 expression was demonstrated in relation to the age in the arteries prone to atherosclerosis; this expression was maximal in arteries from symptomatic patients. In resistant arteries and in veins cholesteryl ester accumulation was rare and light, while ACAT and MDR1 expression was not related to the age of the subjects. CONCLUSIONS: the results showed that an increase in MDR1 and ACAT expression may be responsible for the accumulation of cholesteryl esters as well as for cell growth rate acceleration in vessel sites prone to atherosclerosis.


Subject(s)
Arteriosclerosis/metabolism , Cholesterol Esters/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Adult , Aged , Aorta, Abdominal/metabolism , Carotid Artery, Common/metabolism , Female , Femoral Artery/metabolism , Humans , Iliac Artery/metabolism , Male , Mammary Arteries/metabolism , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Sterol O-Acyltransferase/metabolism
9.
IUBMB Life ; 51(2): 121-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11463164

ABSTRACT

Fluorescent probes are currently used to evaluate the mitochondrial transmembrane potential in situ. However, in parallel experiments using the probes JC-1 and TMRM in different cell types (human astrocytes, HEp-2, Vero, KB, and HeLa cells), we found that the distribution of JC-1 and TMRM is highly variable not only in different cell types but also in different cells of the same cell type, a condition that has never been documented until our work. This phenomenon depends on a hidden, widespread multidrug resistance (MDR) phenotype that can be recognized only by comparative assays with MDR inhibitors (progesterone, verapamil, and cyclosporin A) and represents a serious risk of error in the evaluation of the mitochondrial potential.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors , Cyclosporine/pharmacology , Drug Resistance, Multiple , Fluorescent Dyes , Progesterone/pharmacology , Verapamil/pharmacology , Animals , Cell Line , Humans , Mitochondria/drug effects , Mitochondria/metabolism
10.
Int J Exp Pathol ; 81(4): 241-8, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10971745

ABSTRACT

Sexual dimorphism exists in the response of rats to lead nitrate, liver hyperplasia occuring earlier and being more pronounced in males. Excess dietary choline in females shifted the growth pattern towards that of males. To determine whether phosphatidylcholine-induced growth modulations could be related to a derangement of cholesterol metabolism, liver accumulation of cholesterol esters and plasma lipoprotein patterns were investigated. In males, lead-induced liver hyperplasia was associated with increased total cholesterol hepatic content, accumulated cholesterol esters and reduced concentration of plasma High Density Lipoprotein (HDL) cholesterol. Females were less responsive to the liver mitogenic signal of lead nitrate; there was no elevation of cholesterol content nor any marked accumulation of cholesterol esters. This is consistent with the lack of change in the plasma levels of HDL cholesterol. Continuous choline feeding displaced the liver cholesterol ester pattern and plasma HDL cholesterol levels in females, and in parallel that of DNA synthesis, towards those of males. Choline was not observed to have any effect in males. These results suggest that the derangement of phosphatidylcholine metabolism induces growth-related changes in cholesterol turnover; they are consistent with the proposal that the intracellular content of cholesterol esters may have a role in regulating liver growth rates.


Subject(s)
Cholesterol Esters/metabolism , Choline/pharmacology , Lipoproteins, HDL/blood , Liver/pathology , Animals , Female , Hyperplasia/chemically induced , Hyperplasia/metabolism , Lead , Liver/drug effects , Liver/metabolism , Male , Nitrates , Rats , Rats, Wistar , Sex Characteristics
12.
J Vasc Res ; 36(4): 261-71, 1999.
Article in English | MEDLINE | ID: mdl-10474039

ABSTRACT

Recent studies have shown that a membrane p-glycoprotein, encoded by MDR1 gene, is involved in the transport of free cholesterol from the plasma membrane to endoplasmic reticulum, the site of cholesterol esterification by acyl-CoA:cholesterol acyltransferase (ACAT). Moreover, results deriving from our previous studies have shown that the rate of cell proliferation was positively correlated with cholesteryl ester levels as well as with ACAT and MDR1 gene expression. In this study, lipid content and the expression of the genes involved in cholesterol metabolism such as hydroxy-methylglutaryl coenzyme A reductase (HMGCoA-R), low-density lipoprotein receptor (LDL-R), ACAT and MDR1 have been investigated in control and atherosclerotic arteries. The results have shown that the levels of cholesteryl ester increase with the age of cadaveric donors in arteries prone to atherosclerosis (abdominal aorta, superficial femoral artery) and become predominant in advanced atherosclerotic lesions. The mRNA levels of ACAT and MDR1 showed the same age correlation, reaching the highest values in atherosclerotic specimens. These results suggest that MDR1 may be involved in the accumulation of intracellular cholesterol ester levels found in atherosclerotic lesions. Moreover, the levels of HMGCoA-R, LDL-R and ACAT gene expressions progressively increased with the age of cadaveric donors; conversely, in atherosclerotic specimens, the mRNA levels of HMGCoA-R and LDL-R drastically decreased while ACAT gene expression reached its maximum. These findings suggest a reactivation of normal homeostatic regulation of cholesterol in advanced and complicated lesions.


Subject(s)
Arteriosclerosis/genetics , Cholesterol/metabolism , Genes, MDR , Adult , Aged , Arteries/metabolism , Arteries/pathology , Arteriosclerosis/metabolism , Arteriosclerosis/pathology , Case-Control Studies , Disease Progression , Female , Gene Expression , Humans , Lipid Metabolism , Male , Middle Aged , Reference Values , Reverse Transcriptase Polymerase Chain Reaction
13.
Cancer Lett ; 140(1-2): 53-8, 1999 Jun 01.
Article in English | MEDLINE | ID: mdl-10403541

ABSTRACT

In the present study we examined gene expression and glucose-6-phosphate dehydrogenase (G6PD) activity in leukemic cells isolated from G6PD normal and deficient subjects. The results have shown that G6PD activity strongly increases in G6PD normal leukemic cells as well as in G6PD deficient leukemic cells when compared to peripheral blood mononuclear cells (PBMC). Higher levels of G6PD gene expression were observed in leukemic cells from G6PD deficient patients compared to G6PD normal. A similar pattern of gene expression was also observed for 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase. These results support the hypothesis that G6PD deficient cell, in order to sustain their growth, must respond to the low activity of their mutant enzyme with an increase in quantity through an induction of gene expression.


Subject(s)
Gene Expression , Glucosephosphate Dehydrogenase Deficiency/enzymology , Glucosephosphate Dehydrogenase/metabolism , Leukemia/enzymology , Adult , Cells, Cultured , Humans , Hydroxymethylglutaryl CoA Reductases/metabolism , Leukemia/metabolism , Leukocytes, Mononuclear/enzymology , Leukocytes, Mononuclear/metabolism , Male , Polymerase Chain Reaction , RNA, Messenger/metabolism , Receptors, LDL/metabolism
14.
Cell Prolif ; 32(1): 49-61, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10371303

ABSTRACT

A positive correlation between cholesterol esterification and growth rate potential was previously found in our laboratory during the growth of CEM and MOLT4 lymphoblastic cells. In the current study, we investigated whether the rates of cholesterol esters synthesis correlate with changes of acyl-CoAcholesterol acyltransferase (ACAT) mRNA levels and of other genes implied in cholesterol biosynthesis and uptake, such as 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) reductase and low density lipoprotein (LDL) receptor. The results showed that the more rapid growing CEM cells had lower levels of expression of HMGCoA-reductase and LDL receptors compared to MOLT4. By contrast, ACAT mRNA levels were higher in CEM cells, further supporting the concept of a possible involvement of cholesterol esters in the regulation of cell growth and division. In this study, high levels of cholesterol esterification and of expression of ACAT gene were also associated with a markedly increased expression of multidrug resistance (MDR1) gene, suggesting that MDR1 activity might contribute to regulate the rate of cell growth and division by modulating intracellular cholesterol ester levels.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Cholesterol Esters/metabolism , Leukemia, T-Cell , Animals , Cell Division/physiology , Cholesterol/biosynthesis , DNA Primers , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Hydroxymethylglutaryl CoA Reductases/genetics , Hydroxymethylglutaryl CoA Reductases/metabolism , Mice , RNA, Messenger/analysis , Receptors, LDL/genetics , Receptors, LDL/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sterol O-Acyltransferase/genetics , Sterol O-Acyltransferase/metabolism , Tumor Cells, Cultured/chemistry , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/enzymology
15.
J Nutr ; 129(3): 700-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10082777

ABSTRACT

The ascites hepatoma Yoshida AH130 causes in the host a rapid and progressive body weight loss, associated with reduced food intake, and protein and lipid hypercatabolism. Because insulin regulates glucose as well as lipid and protein metabolism, we suggest that the observed alterations are at least in part secondary to hypoinsulinemia and/or to the increase of counterregulatory hormones in AH130-bearing rats. To verify this hypothesis, controls with free access to food (n = 4), controls with free access to food plus insulin (107 micromol. kg body wt-1. d-1) (n = 4), controls pair-fed to the tumor-bearing rats (n = 4), pair-fed controls treated with insulin (n= 4), tumor hosts (n = 9), and tumor hosts treated with insulin (n = 6) were used. The Yoshida ascites hepatoma cells ( approximately 10(8) cells/rat) were inoculated intraperitoneally. Daily food intake and body weight were measured; insulin was injected starting the day of tumor implantation for 6 d. The metabolism of both cholesterol and lipids was investigated in tumor cells, and ascitic fluid and blood serum were investigated at the end of treatment. Insulin prevented the reduction of food intake (19 +/- 0.6 vs. 13 +/- 0.4 g/d, P < 0.01; AH130 hosts treated and not treated with insulin, respectively), the loss of body weight (202 +/- 12 vs. 135 +/- 9 g, P < 0.01), lowered the circulating triglycerides (48.3 +/- 4.9 vs. 84.5 +/- 7.1 mmol/L, P < 0.01), and free fatty acids (561 +/- 47 vs. 989 +/- 54 mmol/L (P < 0.01), while corrected the decrease of adipose lipoprotein lipase activity (1,240 +/- vs. 300 +/- pmol FA, P < 0.01) observed in AH130 hosts. Moreover, insulin prevented the decrease in HDL cholesterol (13.2 +/- 0.8 vs. 9.3. +/- 0.7 mmol/L, P < 0.01) and significantly increased hepatic cholesterol synthesis as evaluated by 14C-acetate incorporation into cholesterol, in both liver (3,337 +/- 245 vs. 830 +/- 115 Bq/g, P < 0.01) and AH130 cells (11,676 +/- 1,693 vs. 4,196 +/- 527 Bq/10(6) cells, P < 0.01). Thus insulin treatment ameliorated many metabolic derangements, with a lengthening of rats survival time (7 +/- 1 vs. 11 +/- 1 d, P < 0.05) without significantly stimulating tumor growth. These data, together with our previous observations on the effectiveness of insulin on protein turnover perturbations, suggest that many metabolic alterations occurring during cancer cachexia can be avoided by the administration of this hormone.


Subject(s)
Cachexia/metabolism , Cholesterol/metabolism , Insulin/pharmacology , Lipid Metabolism , Liver Neoplasms, Experimental/metabolism , Animals , Blood Glucose/metabolism , Cachexia/etiology , Cholesterol/biosynthesis , Cholesterol/blood , Fatty Acids, Nonesterified/blood , Insulin/blood , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Lipoproteins, VLDL/blood , Liver/metabolism , Liver Neoplasms, Experimental/complications , Male , Rats , Rats, Wistar , Triglycerides/biosynthesis , Triglycerides/blood , Triglycerides/metabolism , Weight Loss
16.
Hum Mutat ; 12(1): 72-3, 1998.
Article in English | MEDLINE | ID: mdl-10627140

ABSTRACT

In this paper we report a male infant heterozygous for thalassemia with a mild glucose 6 phosphate dehydrogenase deficiency. The molecular basis of this new Class III G6PD variant is a G-->T mutation at nucleotide 34 in the exon 2, which predicts a Val-->Leu aminoacid substitution at codon 12. We designated this variant as G6PD Sinnai from the place of birth of the propositus.


Subject(s)
Glucosephosphate Dehydrogenase Deficiency/genetics , Glucosephosphate Dehydrogenase/genetics , Humans , Infant , Isoenzymes/genetics , Male , Mutation/genetics , Thalassemia/enzymology , Thalassemia/genetics
17.
Farmaco ; 53(10-11): 690-2, 1998.
Article in English | MEDLINE | ID: mdl-10205855

ABSTRACT

In the present study, the bezafibrate levels were measured in serum of rats treated with lead nitrate using a high performance liquid chromatography (HPLC) method. The results have shown that the peak corresponding to bezafibrate in the chromatogram is reduced in serum of rats treated with bezafibrate plus lead, indicating that lead treatment accelerates the metabolism of bezafibrate in rats.


Subject(s)
Bezafibrate/blood , Hypolipidemic Agents/blood , Lead/pharmacology , Mitogens/pharmacology , Nitrates/pharmacology , Administration, Oral , Animals , Bezafibrate/metabolism , Chromatography, High Pressure Liquid , Drug Interactions , Hypolipidemic Agents/metabolism , Injections, Intravenous , Male , Rats , Rats, Wistar
18.
Biochem J ; 321 ( Pt 3): 603-8, 1997 Feb 01.
Article in English | MEDLINE | ID: mdl-9032443

ABSTRACT

CEM and MOLT4 are human T-cell lines isolated from patients with acute cell leukaemia. In culture they show important differences in cholesterol metabolism, CEM being less efficient at synthesizing cholesterol and having a lower activity of 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) reductase. To investigate further the relationship between regulation of intracellular cholesterol metabolism at various steps and rate of cell growth, cholesterol synthesis, esterification and efflux were evaluated in CEM and MOLT4 cells at different times during exponential and stationary growth in vitro. It was shown that, although CEM cells have a lower rate of cholesterol synthesis, they grow at a faster rate than MOLT4 cells. However, CEM cells exhibit an increased capacity to esterify cholesterol associated with a decreased efflux of newly synthesized cholesterol into the medium. These results provide evidence for an association between the capability to synthesize and retain cell cholesterol esters and the growth rate potential.


Subject(s)
Cell Division/physiology , Cholesterol Esters/metabolism , Cholesterol/metabolism , Leukemia-Lymphoma, Adult T-Cell/metabolism , Acetates/metabolism , Cholesterol/biosynthesis , DNA/metabolism , Deuterium Oxide/metabolism , Formazans/metabolism , Humans , Hydroxymethylglutaryl CoA Reductases/metabolism , Tetrazolium Salts/metabolism , Tumor Cells, Cultured
19.
Br J Cancer ; 72(5): 1138-43, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7577459

ABSTRACT

Rats transplanted with the ascites hepatoma Yoshida AH-130 developed a severely progressive cachexia, characterised by marked alterations in protein and lipid metabolism. In particular, high levels of serum triglycerides and free fatty acids were associated with altered levels and distribution of plasma cholesterol, with increased total and very low-density lipoprotein-low-density lipoprotein (VLDL-LDL) cholesterol and reduced high-density lipoprotein (HDL) cholesterol. The tumour cells showed high rates of cholesterol synthesis and elevated content of free and esterified cholesterol, whereas total cholesterol synthesis was reduced in the host liver. To determine whether these perturbations could be related to the elevation of tumour necrosis factor alpha (TNF-alpha) previously shown in the AH-130 bearers (Tessitore L, Costelli P, Baccino FM 1993, Br J Cancer, 67, 15-23), either anti-TNF polyclonal antibodies or non-immune IgGs were injected daily after tumour transplantation. The anti-TNF treatment neither affected tumour growth nor prevented the serum cholesterol changes, while attenuating the hypertriglyceridaemia and the elevated serum free fatty acid levels. These data indicate that TNF does not appear to be directly involved in the altered cholesterol metabolism in AH-130 hosts, thus supporting the view that cholesterol metabolism and lipid metabolism are regulated differently during tumour growth.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Cachexia/metabolism , Cholesterol/metabolism , Immunization, Passive , Liver Neoplasms, Experimental/therapy , Neoplasm Proteins/antagonists & inhibitors , Triglycerides/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Ascites , Cachexia/etiology , Cholesterol, HDL/metabolism , Chromatography, High Pressure Liquid , Lipoproteins/blood , Liver/metabolism , Liver Neoplasms, Experimental/complications , Liver Neoplasms, Experimental/metabolism , Male , Neoplasm Proteins/physiology , Neoplasm Transplantation , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/physiology
20.
Clin Sci (Lond) ; 89(5): 505-10, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8549065

ABSTRACT

1. Serum lipids and lipoprotein profiles were determined in children affected by different types of malignancies (leukaemias or lymphomas and solid tumours) both before any treatment and after remission of the disease following chemical or surgical therapy. 2. At the time of diagnosis, children bearing tumours showed hypertriglyceridaemia and reduced concentrations of plasma high-density lipoprotein cholesterol levels, the decrease being particularly prominent in patients with haematological tumours. Children bearing solid tumours displayed an increase of total cholesterol, while those with haematological cancer showed decreased phospholipid levels; low-density lipoprotein cholesterol in neoplastic patients was not significantly different from control values. High triacylglycerol and low high-density lipoprotein cholesterol levels were also evident in cancer patients divided according to age into three groups (0-5, 6-10 and 11-15 years) when compared with age-matched control subjects. Similarly, high triacylglycerol and low high-density lipoprotein cholesterol levels were also observed in both male and female children when patients were divided according to sex and compared with corresponding controls. 3. Clinical remission after therapy was accompanied by an increase of high-density lipoprotein cholesterol levels compared with values observed at diagnosis. In contrast, post-treatment levels of triacylglycerol were higher than those observed before therapy. These results support the hypothesis that alterations of high-density lipoprotein cholesterol levels may be related, at least in part, to the rate of tumour growth, while modifications of triacylglycerol levels may be mediated by different mechanisms.


Subject(s)
Cholesterol, HDL/blood , Hypertriglyceridemia/etiology , Neoplasms/blood , Adolescent , Case-Control Studies , Child , Child, Preschool , Female , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Remission Induction
SELECTION OF CITATIONS
SEARCH DETAIL
...